Lecture 24 Transplantation Immunology Flashcards
autograft
transplant from one anatomical location to another on the same person
isograft
transplant from one individual who is syngeneic to the donor (identical twin) HISTOCOMPATIBLE
allograft
transplant from one individual to a genetically dissimilar individual HISTOINCOMPATIBLE
alloantigens
antigens that differ between members of the same species
xenograft
graft between donor and recipient from different species; HISTOINCOMPATIBLE
Bone Marrow and HSC transplantation
allogeneic and autologous
Which type of transplants would you expect to see rejection?
allograft and xenograft because they are HISTOINCOMPATIBLE
Allogeneic bone marrow transplant runs a risk for
graft vs host disease
Colony stimulating factors include
granulocyte-monocyte-CSF or IL-13
Autologous bone marrow transplant
HSC or bone marrow from same individual following CD34, cryopreservation, ablative therapy followed by reintroduction of frozen HSC
First-set rejection
first graft from a histoincompatible donor leads to rejection in 2 weeks
Second-set rejection (immunological memory)
second graft from the same donor will be completely rejected within a week
which type of individuals would not reject an allograft
athymic - T cell plays a large role in rejection
Hyperacute rejection
within hours, pre-formed antibodies to incompatible MHC or blood group antigens and activation of complement causes a reaction
Hyperacute rejection is mediated by
present antibodies binding to tissue inducing complement and recruitment of phagocytic cells, platelet activation -> thrombosis -> hemorrhage -> necrosis
Pre-formed antibodies may be present as a result of
ABO incompatibility, previous incompatible transfusion, pre void blood transfusion from related donor, pregnancy
Manifestations of hyperacute rejection
fever, leukocytosis, loss of function of organ
Therapy for hyperacute rejection
NONE
Acute rejection
within days, non-sensitized patients’ T cell-mediated immunity recognizes mismatch of HLA types
Acute rejection is complete by
14 days, may be shorter in sensitized patients
Acute rejection occurs when
there is a mismatch or incomplete match in HLA types
Histological definition of acute rejection
infiltration of lymphocytes and monocytic macrophages
destruction of cells in acute rejection occurs by
cytotoxic T cells, phagocytosis and presentation of transplant antigen to help T cells
Therapy for acute rejection
immunsuppressive therapy (antibodies against T lymphocytes, corticosteroids, or other drugs)
Histological definition of chronic rejection
lymphoid proliferation and formation of lymphoid follicles, fibrotic changes
Chronic rejection
over months or years, CD4+ cell activation along with macrophage activation, cytotoxic T cell activation, antibody produced against allograft antigens, classical complement, and ADCC cause loss of function of organ
Therapy for chronic rejection
none, damage has been done
Graft vs host disease
transplantation of donor lymphocytes or precursors genetically dissimilar can ATTACK RECIPIENT’s tissue
To avoid Graft vs host disease
immunocompetent lymphocytes from donor and recipient must be immune compromised
Manifestations of Graft vs host disease
rash, hepato-slpenomagaly, lymphadenopathy, diarrhea, anemia, weight loss, wasting
Graft-versus-leukemia effect
donor T cells recognize minor histocompatibility or tumor-specific antigens and attack and kill leukemic cells, reducing the reoccurrence